3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Surgical Wound Infection
4
Colorectal Neoplasms
4
Neoplasms
3
Sepsis
2
Pancreatic Neoplasms
2
Leukemia, Myeloid, Acute
2
Febrile Neutropenia
2
Triple Negative Breast Neoplasms
1
Solitary Pulmonary Nodule
1
Skin Neoplasms
1
Rectal Neoplasms
1
Pancreatic Fistula
1
Neutropenia
1
Neoplasms, Plasma Cell
1
Multiple Pulmonary Nodules
1
Multiple Endocrine Neoplasia Type 1
1
Melanoma
1
Lung Neoplasms
1
Intestinal Neoplasms
1
Inflammation
1
Infections
1
Glioblastoma
1
Fever
1
Exanthema
1
Emergencies
1
Duodenal Neoplasms
1
Discitis
1
Diarrhea
1
Colonic Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Pancreaticojejunostomy
4
Octreotide
2
Endoscopic Mucosal Resection
2
apixaban
1
X-Rays
1
Ursodeoxycholic Acid
1
Tissue Adhesives
1
Tea
1
Surgical Procedures, Operative
1
Stents
1
Sodium Chloride
1
Rivaroxaban
1
Radiotherapy
1
Radiosurgery
1
Phantoms, Imaging
1
Pantoprazole
1
Nutritional Status
1
Nutrition Therapy
1
Irinotecan
1
Iopamidol
1
Hydromorphone
1
Hydrocortisone
1
High-Energy Shock Waves
1
Enteral Nutrition
1
Endoscopy, Digestive System
1
Endoscopic Ultrasound-Guided Fine Needle Aspiration
1
Dietary Supplements
1
Diet
1
Dalteparin
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Duodenal Neoplasms
×
Anti-Bacterial Agents
×
Clear all
NCT03631173
2026-04-28
MINIMUM
Oslo University Hospital
Phase NA
Active not recruiting
201 enrolled